Glafenine structure
|
Common Name | Glafenine | ||
---|---|---|---|---|
CAS Number | 3820-67-5 | Molecular Weight | 372.80200 | |
Density | 1.428g/cm3 | Boiling Point | 618ºC at 760 mmHg | |
Molecular Formula | C19H17ClN2O4 | Melting Point | 170℃ | |
MSDS | Chinese USA | Flash Point | 327.6ºC |
Use of GlafenineGlafenine is a non-steroidal anti-inflammatory drug (NSAID), is a non-narcotic analgesic agent, widely used for the treatment of pains of various origins. |
Name | glafenine |
---|---|
Synonym | More Synonyms |
Description | Glafenine is a non-steroidal anti-inflammatory drug (NSAID), is a non-narcotic analgesic agent, widely used for the treatment of pains of various origins. |
---|---|
Related Catalog |
Density | 1.428g/cm3 |
---|---|
Boiling Point | 618ºC at 760 mmHg |
Melting Point | 170℃ |
Molecular Formula | C19H17ClN2O4 |
Molecular Weight | 372.80200 |
Flash Point | 327.6ºC |
Exact Mass | 372.08800 |
PSA | 91.68000 |
LogP | 3.21480 |
Index of Refraction | 1.696 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
~75% Glafenine CAS#:3820-67-5 |
Literature: Mouzin; Cousse; Autin Synthesis, 1980 , vol. No. 1, p. 54 - 55 |
~% Glafenine CAS#:3820-67-5 |
Literature: Mouzin; Cousse; Autin Synthesis, 1980 , vol. No. 1, p. 54 - 55 |
HS Code | 2933499090 |
---|---|
Summary | 2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Chem. Res. Toxicol. 23 , 171-83, (2010) Drug-induced liver injury is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical structures is critical to help guide experimental... |
|
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
J. Sci. Ind. Res. 65(10) , 808, (2006) Drug-induced liver injury (DILI) is a significant concern in drug development due to the poor concordance between preclinical and clinical findings of liver toxicity. We hypothesized that the DILI typ... |
|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Chem. Res. Toxicol. 23 , 1215-22, (2010) Drug-induced liver injury is a major issue of concern and has led to the withdrawal of a significant number of marketed drugs. An understanding of structure-activity relationships (SARs) of chemicals ... |
2,3-dihydroxypropyl 2-[(7-chloroquinolin-4-yl)amino]benzoate |
1-Glyceryl N-(7-chloro-4-quinolyl)anthranilate |
2,3-Dihydroxypropyl 2-((7-chloroquinolin-4-yl)amino)benzoate |